Typhoid VI polysacc
Ended Awarded
- Contract number
- SPE2DP25F8784
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,690
Award facts
- Contract value 100% obligated
- $16,690.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $16,690.14 to DMS Pharmaceutical Group Inc. on June 26, 2025, for the supply of Typhoid VI Polysaccharide vaccine. This firm fixed-price delivery order, with an ultimate completion date of July 7, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program valued at $499,999,999 and valid through November 2026, which serves as the overarching vehicle for this delivery order.
DMS Pharmaceutical Group Inc. is an established federal pharmaceutical supplier registered in SAM.gov since 2001, specializing in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military and federal healthcare facilities nationwide. The company's robust portfolio of federal contract awards demonstrates its critical role in supporting the Department of Defense's medical supply chain. This delivery order for Typhoid VI Polysaccharide vaccine aligns with the company's core mission of providing essential pharmaceutical products and vaccines to support military health facilities globally.
Quick answers
Who was awarded contract SPE2DP25F8784?
SPE2DP25F8784 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 26, 2025.
How much is contract SPE2DP25F8784 worth?
The government has obligated $16,690 on SPE2DP25F8784.
Is contract SPE2DP25F8784 an order under another contract?
Yes. SPE2DP25F8784 is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F8784 competed?
The extent of competition for SPE2DP25F8784 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award